AB-598

N/A

Report date: 2025/06/06 20:01:13

Base Information

Drug NameAB-598
Drug Alias NameAB598
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Ectonucleoside triphosphate diphosphohydrolase 1
TargetsEctonucleoside triphosphate diphosphohydrolase 1
Therapy Area/IndicationsUrinary Bladder NeoplasmsUterine Cervical NeoplasmsCarcinoma, Non-Small-Cell Lung +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwanAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesArcus Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesArcus Biosciences Inc
Inactive CompaniesN/A
Active IndicationsUrinary Bladder NeoplasmsUterine Cervical NeoplasmsCarcinoma, Non-Small-Cell Lung +[9] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A